FILE PHOTO: People pose with syringe with needle in front of displayed Moderna logo in this illustration taken, December 11, 2021. REUTERS/Dado Ruvic/Illustration/File Photo April 21 (Reuters) - ...

The company said the first participants have already received a shot. HealthDay News — A new effort to prepare for future bird flu outbreaks is moving forward, despite a major funding setback. The ...

The first ever avian influenza vaccine recently started trials in the US. This marks a milestone in the prevention of bird ...

The Moderna Innovation and Technology Centre in Harwell is now fully operational. The NHS Covid spring booster campaign is under way, but vaccines are also available privately. The easily spreadable ...

The U.S. Food and Drug Administration (FDA) recently informed Moderna that it would not review the company’s application for approval of its new flu vaccine, which is its first using mRNA technology ...

Moderna has begun a large-scale clinical trial of its mRNA-based bird flu vaccine, enrolling about 4,000 adults in the U.S. and U.K. The move follows earlier promising safety and immune response data ...

A program that got caught up in HHS’ decision to abandon mRNA research was revived by a public-private coalition and is now beginning a large, late-stage test that could support a future approval.

Moderna (MRNA) announced on Wednesday that the company has initiated dosing in a Phase 3 trial designed to evaluate its messenger RNA-based bird flu vaccine candidate, mRNA-1018, in the U.S. and U.K.

April 21 (Reuters) - Moderna said on Tuesday it had started a late-stage study of its experimental bird flu vaccine in the U.S. and the UK, marking the first time a pandemic bird flu vaccine made with ...